Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Effective Spin Traps to Treat Stroke
Maples, Kirk R.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 9 grants from Kirk Maples
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mitigation of Neurological Damage Following Seizures
Grants for Graduate Training in Family Medicine
Biomedical Research Support
Evaluation of Congeners of New Lead Compounds
Meeting: With a Little help from my Friends: Microbial Partners in Integrative and Comparative Biology, a Symposium for the Society for Integrative and Comparative Biology (SICB)
Recently added grants:
Omics for TB: Response to Infection and Treatment
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events
Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive persons
Adminstrative Core
Technology Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS032597-03
Application #
2037760
Study Section
Special Emphasis Panel (ZRG1-BPO (01))
Program Officer
Jacobs, Tom P
Project Start
1994-02-01
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Related projects
NIH 1996
R44 NS
Development of Effective Spin Traps to Treat Stroke
Maples, Kirk R. / Centaur Pharmaceuticals, Inc.
NIH 1995
R44 NS
Development of Effective Spin Traps to Treat Stroke
Maples, Kirk R. / Centaur Pharmaceuticals, Inc.
Comments
Be the first to comment on Kirk Maples's grant